{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:27:26Z","timestamp":1793395646435,"version":"4.5.0"},"reference-count":102,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":874,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Immunol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1111\/cei.12038","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T05:07:59Z","timestamp":1353647279000},"page":"148-157","source":"Crossref","is-referenced-by-count":141,"title":["Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?"],"prefix":"10.1093","volume":"172","author":[{"given":"C. M. U.","family":"Hilkens","sequence":"first","affiliation":[{"name":"Institute of Cellular Medicine; Newcastle University; Newcastle upon Tyne; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Isaacs","sequence":"additional","affiliation":[{"name":"Institute of Cellular Medicine; Newcastle University; Newcastle upon Tyne; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"10.1111\/cei.12038-BIB0001|cei12038-cit-0001","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1073\/pnas.86.2.636","article-title":"Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis","volume":"86","author":"Londei","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/cei.12038-BIB0002|cei12038-cit-0002","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.169.2.1068","article-title":"Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis","volume":"169","author":"Fritsch","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0003|cei12038-cit-0003","doi-asserted-by":"crossref","first-page":"17180","DOI":"10.1073\/pnas.0407704101","article-title":"Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis","volume":"101","author":"Bilsen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/cei.12038-BIB0004|cei12038-cit-0004","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/ard.2008.103978","article-title":"Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T-cell responses in rheumatoid arthritis and osteoarthritis","volume":"69","author":"Jong","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/cei.12038-BIB0005|cei12038-cit-0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/art.25059","article-title":"Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis","volume":"62","author":"Feitsma","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0006|cei12038-cit-0006","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/art.27594","article-title":"HLA-DR1001 presents \u2018altered-self\u2019 peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets","volume":"62","author":"James","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0007|cei12038-cit-0007","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/art.25064","article-title":"Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis","volume":"62","author":"Delwig","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0008|cei12038-cit-0008","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00296-011-2039-z","article-title":"Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles","volume":"32","author":"Catalan","year":"2012","journal-title":"Rheum Int"},{"key":"10.1111\/cei.12038-BIB0009|cei12038-cit-0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"issue":"4","key":"10.1111\/cei.12038-BIB0010|cei12038-cit-0010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007848","article-title":"Biologics for rheumatoid arthritis: an overview of Cochrane reviews","author":"Singh","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/cei.12038-BIB0011|cei12038-cit-0011","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1517\/14712590903379494","article-title":"Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists","volume":"9","author":"Isaacs","year":"2009","journal-title":"Exp Opin Biol Ther"},{"key":"10.1111\/cei.12038-BIB0012|cei12038-cit-0012","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/rheumatology\/kel236","article-title":"Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients","volume":"46","author":"Salliot","year":"2007","journal-title":"Rheumatology"},{"key":"10.1111\/cei.12038-BIB0013|cei12038-cit-0013","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"Gomez-Reino","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0014|cei12038-cit-0014","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1111\/cei.12038-BIB0015|cei12038-cit-0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1073\/pnas.231606698","article-title":"Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance","volume":"99","author":"Steinman","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/cei.12038-BIB0016|cei12038-cit-0016","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.20082394","article-title":"Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity","volume":"206","author":"Ohnmacht","year":"2009","journal-title":"J Exp Med"},{"key":"10.1111\/cei.12038-BIB0017|cei12038-cit-0017","first-page":"575","article-title":"Human dendritic cell deficiency: the missing ID? Nature reviews","volume":"11","author":"Collin","year":"2011","journal-title":"Immunology"},{"key":"10.1111\/cei.12038-BIB0018|cei12038-cit-0018","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/cei.12038-BIB0019|cei12038-cit-0019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1074-7613(03)00182-1","article-title":"Dendritic cells in immunity and tolerance - do they display opposite functions?","volume":"19","author":"Moser","year":"2003","journal-title":"Immunity"},{"key":"10.1111\/cei.12038-BIB0020|cei12038-cit-0020","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.192.9.1213","article-title":"Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells","volume":"192","author":"Jonuleit","year":"2000","journal-title":"J Exp Med"},{"key":"10.1111\/cei.12038-BIB0021|cei12038-cit-0021","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J Exp Med"},{"key":"10.1111\/cei.12038-BIB0022|cei12038-cit-0022","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1074-7613(03)00120-1","article-title":"Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance","volume":"18","author":"Probst","year":"2003","journal-title":"Immunity"},{"key":"10.1111\/cei.12038-BIB0023|cei12038-cit-0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-540-71029-5_1","article-title":"Activation of dendritic cells by Toll-like receptors and C-type lectins","volume":"188","author":"Diebold","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1111\/cei.12038-BIB0024|cei12038-cit-0024","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0167-5699(99)01547-9","article-title":"T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal","volume":"20","author":"Kalinski","year":"1999","journal-title":"Immunol Today"},{"key":"10.1111\/cei.12038-BIB0025|cei12038-cit-0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/icb.2008.26","article-title":"Determination of T-cell fate by dendritic cells","volume":"86","author":"Diebold","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"10.1111\/cei.12038-BIB0026|cei12038-cit-0026","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20011288","article-title":"Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis","volume":"195","author":"McGuirk","year":"2002","journal-title":"J Exp Med"},{"key":"10.1111\/cei.12038-BIB0027|cei12038-cit-0027","doi-asserted-by":"crossref","first-page":"48122","DOI":"10.1074\/jbc.M206941200","article-title":"A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization","volume":"277","author":"Kleij","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1111\/cei.12038-BIB0028|cei12038-cit-0028","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jlb.66.2.201","article-title":"Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3","volume":"66","author":"Jong","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1111\/cei.12038-BIB0029|cei12038-cit-0029","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1182\/blood.V99.7.2468","article-title":"CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity","volume":"99","author":"Steinbrink","year":"2002","journal-title":"Blood"},{"key":"10.1111\/cei.12038-BIB0030|cei12038-cit-0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1074-7613(03)00055-4","article-title":"Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse","volume":"18","author":"Sato","year":"2003","journal-title":"Immunity"},{"key":"10.1111\/cei.12038-BIB0031|cei12038-cit-0031","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.4049\/jimmunol.177.9.5868","article-title":"\u2018Alternatively activated\u2019 dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig","volume":"177","author":"Lan","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0032|cei12038-cit-0032","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/cei.12038-BIB0033|cei12038-cit-0033","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1146\/annurev-immunol-020711-075043","article-title":"Induced CD4+Foxp3+ regulatory T cells in immune tolerance","volume":"30","author":"Bilate","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/cei.12038-BIB0034|cei12038-cit-0034","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"10.1111\/cei.12038-BIB0035|cei12038-cit-0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fimmu.2012.00030","article-title":"The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells","volume":"3","author":"Gregori","year":"2012","journal-title":"Front Immunol"},{"key":"10.1111\/cei.12038-BIB0036|cei12038-cit-0036","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-12-380995-7.00004-5","article-title":"How tolerogenic dendritic cells induce regulatory T cells","volume":"108","author":"Maldonado","year":"2010","journal-title":"Adv Immunol"},{"key":"10.1111\/cei.12038-BIB0037|cei12038-cit-0037","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01015.x","article-title":"Dendritic cell control of tolerogenic responses","volume":"241","author":"Manicassamy","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1111\/cei.12038-BIB0038|cei12038-cit-0038","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4049\/jimmunol.171.4.1652","article-title":"Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion","volume":"171","author":"Mellor","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0039|cei12038-cit-0039","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2008.06.017","article-title":"Plasmacytoid dendritic cells mediate oral tolerance","volume":"29","author":"Goubier","year":"2008","journal-title":"Immunity"},{"key":"10.1111\/cei.12038-BIB0040|cei12038-cit-0040","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"key":"10.1111\/cei.12038-BIB0041|cei12038-cit-0041","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1084\/jem.20070602","article-title":"Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 Treg cells via retinoic acid","volume":"204","author":"Sun","year":"2007","journal-title":"J Exp Med"},{"key":"10.1111\/cei.12038-BIB0042|cei12038-cit-0042","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.172.8.4676","article-title":"Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells","volume":"172","author":"Misra","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0043|cei12038-cit-0043","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4049\/jimmunol.177.1.40","article-title":"Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells","volume":"177","author":"Kryczek","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0044|cei12038-cit-0044","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.smim.2011.06.007","article-title":"Tolerogenic dendritic cells and their role in transplantation","volume":"23","author":"Ezzelarab","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1111\/cei.12038-BIB0045|cei12038-cit-0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOT.0b013e32834ee662","article-title":"Tolerogenic dendritic cells: applications for solid organ transplantation","volume":"17","author":"Beriou","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/cei.12038-BIB0046|cei12038-cit-0046","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.cji.0000210081.60178.b4","article-title":"Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity","volume":"29","author":"Voigtlander","year":"2006","journal-title":"J Immunother"},{"key":"10.1111\/cei.12038-BIB0047|cei12038-cit-0047","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/eji.200838987","article-title":"Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice","volume":"39","author":"Lim","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1111\/cei.12038-BIB0048|cei12038-cit-0048","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1084\/jem.191.5.795","article-title":"Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease","volume":"191","author":"Ludewig","year":"2000","journal-title":"J Exp Med"},{"key":"10.1111\/cei.12038-BIB0049|cei12038-cit-0049","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1002\/art.27756","article-title":"Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses","volume":"62","author":"Stoop","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0050|cei12038-cit-0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/08830180903281193","article-title":"Development of dendritic cell-based immunotherapy for autoimmunity","volume":"29","author":"Hilkens","year":"2010","journal-title":"Int Rev Immunol"},{"key":"10.1111\/cei.12038-BIB0051|cei12038-cit-0051","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jlb.66.6.909","article-title":"Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells","volume":"66","author":"Matasic","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1111\/cei.12038-BIB0052|cei12038-cit-0052","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1006\/mthe.2000.0060","article-title":"Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides","volume":"1","author":"Giannoukakis","year":"2000","journal-title":"Mol Ther"},{"key":"10.1111\/cei.12038-BIB0053|cei12038-cit-0053","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0054|cei12038-cit-0054","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/art.22655","article-title":"Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB","volume":"56","author":"Martin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0055|cei12038-cit-0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1189\/jlb.1107744","article-title":"Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells","volume":"84","author":"Anderson","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1111\/cei.12038-BIB0056|cei12038-cit-0056","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/sj.gt.3300862","article-title":"Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients","volume":"6","author":"Lu","year":"1999","journal-title":"Gene Ther"},{"key":"10.1111\/cei.12038-BIB0057|cei12038-cit-0057","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.4049\/jimmunol.166.5.3499","article-title":"Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4","volume":"166","author":"Kim","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0058|cei12038-cit-0058","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI11490","article-title":"Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis","volume":"107","author":"Morita","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1111\/cei.12038-BIB0059|cei12038-cit-0059","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/sj.gt.3301513","article-title":"Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice","volume":"8","author":"Coates","year":"2001","journal-title":"Gene Ther"},{"key":"10.1111\/cei.12038-BIB0060|cei12038-cit-0060","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2005-05-1826","article-title":"Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression","volume":"106","author":"Tan","year":"2005","journal-title":"Blood"},{"key":"10.1111\/cei.12038-BIB0061|cei12038-cit-0061","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4049\/jimmunol.164.1.161","article-title":"Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival","volume":"164","author":"Min","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0062|cei12038-cit-0062","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1525-0016(02)90712-4","article-title":"Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL","volume":"6","author":"Kim","year":"2002","journal-title":"Mol Ther"},{"key":"10.1111\/cei.12038-BIB0063|cei12038-cit-0063","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1172\/JCI200319209","article-title":"CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis","volume":"112","author":"Liu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/cei.12038-BIB0064|cei12038-cit-0064","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.TP.0000076470.35404.49","article-title":"Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival","volume":"76","author":"Liang","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/cei.12038-BIB0065|cei12038-cit-0065","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.transproceed.2006.03.022","article-title":"Prolongation of rat intestinal allograft survival by administration of donor interleukin-12 p35-silenced bone marrow-derived dendritic cells","volume":"38","author":"Xu","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/cei.12038-BIB0066|cei12038-cit-0066","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-10-19","article-title":"Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis","volume":"10","author":"Li","year":"2012","journal-title":"J Transl Med"},{"key":"10.1111\/cei.12038-BIB0067|cei12038-cit-0067","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of tolerance by IL-10-treated dendritic cells","volume":"159","author":"Steinbrink","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0068|cei12038-cit-0068","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2249.2002.01748.x","article-title":"Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis","volume":"127","author":"Yarilin","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/cei.12038-BIB0069|cei12038-cit-0069","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2011.11.011","article-title":"IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction - a comparative study of human clinical-applicable DC","volume":"142","author":"Boks","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1111\/cei.12038-BIB0070|cei12038-cit-0070","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","article-title":"Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance","volume":"178","author":"Turnquist","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0071|cei12038-cit-0071","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/ard.2007.072199","article-title":"Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells","volume":"67","author":"Salazar","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/cei.12038-BIB0072|cei12038-cit-0072","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1398-9995.2011.02776.x","article-title":"MicroRNA-23b promotes tolerogenic properties of dendritic cells in vitro through inhibiting Notch1\/NF-kappaB signalling pathways","volume":"67","author":"Zheng","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/cei.12038-BIB0073|cei12038-cit-0073","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.4049\/jimmunol.1101243","article-title":"Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features","volume":"187","author":"Valencia","year":"2011","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0074|cei12038-cit-0074","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1136\/ard.2011.151654","article-title":"Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?","volume":"70","author":"Stoop","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/cei.12038-BIB0075|cei12038-cit-0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.24229","article-title":"Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models","volume":"60","author":"Bianco","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0076|cei12038-cit-0076","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"issue":"Suppl 3","key":"10.1111\/cei.12038-BIB0077|cei12038-cit-0077","first-page":"169","article-title":"Safety and preliminary evidence of efficacy in a phase I clinical trial of autologous tolerising dendritic cells exposed to citrullinated peptides (Rheumavax) in patients with rheumatoid arthritis","volume":"70","author":"Thomas","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/cei.12038-BIB0078|cei12038-cit-0078","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/eji.201141835","article-title":"Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients","volume":"42","author":"Raich-Regue","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1111\/cei.12038-BIB0079|cei12038-cit-0079","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.173.7.4331","article-title":"Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells","volume":"173","author":"Machen","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0080|cei12038-cit-0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1074-7613(02)00503-4","article-title":"Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10","volume":"18","author":"Martin","year":"2003","journal-title":"Immunity"},{"key":"10.1111\/cei.12038-BIB0081|cei12038-cit-0081","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.4049\/jimmunol.173.3.1671","article-title":"T cells signaled by NF-kappa B-dendritic cells are sensitized not anergic to subsequent activation","volume":"173","author":"Thompson","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0082|cei12038-cit-0082","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1189\/jlb.0608374","article-title":"LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells","volume":"85","author":"Anderson","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1111\/cei.12038-BIB0083|cei12038-cit-0083","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1136\/ard.2009.126383","article-title":"Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis","volume":"69","author":"Harry","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/cei.12038-BIB0084|cei12038-cit-0084","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.191.6.927","article-title":"The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli","volume":"191","author":"Inaba","year":"2000","journal-title":"J Exp Med"},{"key":"10.1111\/cei.12038-BIB0085|cei12038-cit-0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4049\/jimmunol.177.2.863","article-title":"Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival","volume":"177","author":"Garrod","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0086|cei12038-cit-0086","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4049\/jimmunol.168.4.1579","article-title":"L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific tolerance","volume":"168","author":"Bai","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0087|cei12038-cit-0087","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.4049\/jimmunol.174.11.6993","article-title":"Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells","volume":"174","author":"Ochando","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0088|cei12038-cit-0088","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/art.1780351206","article-title":"The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium","volume":"35","author":"Cush","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0089|cei12038-cit-0089","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.4049\/jimmunol.152.5.2613","article-title":"Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells","volume":"152","author":"Thomas","year":"1994","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0090|cei12038-cit-0090","doi-asserted-by":"crossref","first-page":"R567","DOI":"10.1186\/ar1445","article-title":"Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4+ T cells from patients with rheumatoid arthritis","volume":"6","author":"Yamana","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/cei.12038-BIB0091|cei12038-cit-0091","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.4049\/jimmunol.177.11.8226","article-title":"Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition","volume":"177","author":"Zhu","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0092|cei12038-cit-0092","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4419-1603-7_10","article-title":"Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results","volume":"667","author":"Cluff","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/cei.12038-BIB0093|cei12038-cit-0093","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2003.010033","article-title":"High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering","volume":"63","author":"Radstake","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/cei.12038-BIB0094|cei12038-cit-0094","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/ard.2009.110502","article-title":"Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritis","volume":"69","author":"Baldwin","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/cei.12038-BIB0095|cei12038-cit-0095","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.4049\/jimmunol.169.11.6625","article-title":"Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages","volume":"169","author":"Tsark","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/cei.12038-BIB0096|cei12038-cit-0096","doi-asserted-by":"crossref","first-page":"M110","DOI":"10.1074\/mcp.M110.002477","article-title":"Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis","volume":"10","author":"Seward","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"10.1111\/cei.12038-BIB0097|cei12038-cit-0097","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/art.37720","article-title":"The RA synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen and beta-actin","volume":"65","author":"Beers","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0098|cei12038-cit-0098","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1182\/blood-2011-09-380048","article-title":"A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy","volume":"119","author":"Canavan","year":"2012","journal-title":"Blood"},{"key":"10.1111\/cei.12038-BIB0099|cei12038-cit-0099","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1172\/JCI59411","article-title":"Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation","volume":"122","author":"Bohne","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1111\/cei.12038-BIB0100|cei12038-cit-0100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/cei.12038-BIB0101|cei12038-cit-0101","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nri2804","article-title":"The changing face of rheumatoid arthritis: sustained remission for all?","volume":"10","author":"Isaacs","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/cei.12038-BIB0102|cei12038-cit-0102","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/qjmed\/hcn006","article-title":"A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritis","volume":"101","author":"Morgan","year":"2008","journal-title":"Q J Med"}],"container-title":["Clinical & Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12038","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/cei.12038\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:27:03Z","timestamp":1687825623000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cei.12038"}},"subtitle":["Current status of tolDC therapy"],"short-title":[],"issued":{"date-parts":[[2013,4,10]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12038","relation":{},"ISSN":["0009-9104"],"issn-type":[{"value":"0009-9104","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,10]]}}}